Global DNA methylation as a possible biomarker for diabetic retinopathy

Diabetes/Metabolism Research and Reviews

Volumn 31, Issue 2, 2015, Pages 183-189

  Maghbooli, Zhila ^a   Hossein nezhad, Arash ^a,b   Larijani, Bagher ^a   Amini, Manochehr ^c   Keshtkar, Abbasali ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetic retinopathy; DNA methylation; Epigenetic; Metabolic memory; Type 2 diabetes

Indexed keywords

5 METHYLCYTOSINE; BIOLOGICAL MARKER;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DNA METHYLATION; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; RISK FACTOR; ANALYSIS; BLOOD; COMPLICATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; IRAN; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; UPREGULATION; VITREORETINOPATHY, PROLIFERATIVE;

5-METHYLCYTOSINE; ANALYTIC SAMPLE PREPARATION METHODS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISEASE PROGRESSION; DNA METHYLATION; FEMALE; HUMANS; HYDROLYSIS; IRAN; LEUKOCYTES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; UP-REGULATION; VITREORETINOPATHY, PROLIFERATIVE;

EID: 84922674024     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2584     Document Type: Article

References (52)

1. Mohamed Q, Gillies MC, Wong TY. Management of diabetic retinopathy: a systematic review. JAMA 2007; 298(8): 902-916.
2. Zheng Y, He M, Congdon N. The worldwide epidemic of diabetic retinopathy. Indian J Ophthalmol 2012; 60(5): 428-431.
3. Federation ID. IDF Diabetes Atlas (4th edn). International Diabetes Federation, 2009. www.eatlas.idf.org
4. Petrovic D. Candidate genes for proliferative diabetic retinopathy. Biomed Res Int 2013; 2013: 540416.
5. Kowluru RA, Santos JM, Mishra M. Epigenetic modifications and diabetic retinopathy. Biomed Res Int 2013; 2013: 635284.
6. Ling C, Groop L. Epigenetics: a molecular link between environmental factors and type 2 diabetes. Diabetes 2009; 58(12): 2718-2725.
7. White NH, Sun W, Clearly PA, et al. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial. Arch Ophthalmol 2008; 126(12): 1707-1715.
8. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002; 287(19): 2563-2569.
9. Implications of the United Kingdom Prospective Diabetes Study. American Diabetes Association. Diabetes Care 1998; 21(12): 2180-2184.
10. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care 1999; 22(1): 99-111.
11. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med 2000; 342(6): 381-389.
12. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359(15): 1577-1589.
13. Zhang L, Chen B, Tang L. Metabolic memory: mechanisms and implications for diabetic retinopathy. Diabetes Res Clin Pract 2012; 96(3): 286-293.
14. Drzewoski J, Kasznicki J, Trojanowski Z. The role of "metabolic memory" in the natural history of diabetes mellitus. Pol Arch Med Wewn 2009; 119(7-8): 493-500.
15. Ceriello A. Hypothesis: the "metabolic memory", the new challenge of diabetes. Diabetes Res Clin Pract 2009; 86(Suppl 1): S2-S6.
16. Ceriello A, Ihnat MA, Thorpe JE. Clinical review 2: The "metabolic memory": is more than just tight glucose control necessary to prevent diabetic complications? J Clin Endocrinol Metab 2009; 94(2): 410-415.
17. Klein R. The epidemiology of diabetic retinopathy: findings from the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Int Ophthalmol Clin 1987; 27(4): 230-238.
18. Rossing K, Jacobsen P, Rossing P, Lauritzen E, Lund-Andersen H, Parving HH. Improved visual function in IDDM patients with unchanged cumulative incidence of sight-threatening diabetic retinopathy. Diabetes Care 1998; 21(11): 2007-2015.
19. Ismail-Beigi F, Craven T, Banerji MA, et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 2010; 376(9739): 419-430.
20. Engerman RL, Kern TS. Progression of incipient diabetic retinopathy during good glycemic control. Diabetes 1987; 36(7): 808-812.
21. Hammes HP, Klinzing I, Wiegand S, Bretzel RG, Cohen AM, Federlin K. Islet transplantation inhibits diabetic retinopathy in the sucrose-fed diabetic Cohen rat. Invest Ophthalmol Vis Sci 1993; 34(6): 2092-2096.
22. Engerman RL, Kern TS. Retinopathy in galactosemic dogs continues to progress after cessation of galactosemia. Arch Ophthalmol 1995; 113(3): 355-358.
23. Kador PF, Takahashi Y, Akagi Y, et al. Effect of galactose diet removal on the progression of retinal vessel changes in galactose-fed dogs. Invest Ophthalmol Vis Sci 2002; 43(6): 1916-1921.
24. Cusick M, Chew EY, Ferris F 3rd, Cox TA, Chan CC, Kador PF. Effects of aldose reductase inhibitors and galactose withdrawal on fluorescein angiographic lesions in galactose-fed dogs. Arch Ophthalmol 2003; 121(12): 1745-1751.
25. Motiejunaite R, Kazlauskas A. Pericytes and ocular diseases. Exp Eye Res 2008; 86(2): 171-177.
26. Patel MS, Srinivasan M. Metabolic programming: causes and consequences. J Biol Chem 2002; 277(3): 1629-1632.
27. Thompson RF, Fazzari MJ, Niu H, Barzilai N, Simmons RA, Greally JM. Experimental intrauterine growth restriction induces alterations in DNA methylation and gene expression in pancreatic islets of rats. J Biol Chem 2010; 285(20): 15111-15118.
28. El Hajj N, Pliushch G, Schneider E, et al. Metabolic programming of MEST DNA methylation by intrauterine exposure to gestational diabetes mellitus. Diabetes 2013; 62(4): 1320-1328.
29. Ling C, Del Guerra S, Lupi R, et al. Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia 2008; 51(4): 615-622.
30. Tewari S, Zhong Q, Santos JM, Kowluru RA. Mitochondria DNA replication and DNA methylation in the metabolic memory associated with continued progression of diabetic retinopathy. Invest Ophthalmol Vis Sci 2012; 53(8): 4881-4888.
31. Schubert HD. In 2013-2014 Basic and Clinical Science Course, Section 12: Retina and Vitreous, Regillo CD (ed). American Academy of Ophthalmology: San Francisco, California, 2013.
32. Standards of medical care for patients with diabetes mellitus. Diabetes care. American Diabetes Association. Conn Med 1991; 55(11): 630-633.
33. Ramsahoye BH. Measurement of genome-wide DNA cytosine-5 methylation by reversed-phase high-pressure liquid chromatography. Methods Mol Biol 2002; 200: 17-27.
34. Olsen AS, Sarras MP Jr, Leontovich A, Intine RV. Heritable transmission of diabetic metabolic memory in zebrafish correlates with DNA hypomethylation and aberrant gene expression. Diabetes 2012; 61(2): 485-491.
35. Sapienza C, Lee J, Powell J, et al. DNA methylation profiling identifies epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy. Epigenetics 2011; 6(1): 20-28.
36. Bell CG, Teschendorff AE, Rakyan VK, Maxwell AP, Beck S, Savage DA. Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus. BMC Med Genomics 2010; 3: 33.
37. Stenvinkel P, Karimi M, Johansson S, et al. Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease? J Intern Med 2007; 261(5): 488-499.
38. Hallman DM, Boerwinkle E, Gonzalez VH, Klein BE, Klein R, Hanis CL. A genome-wide linkage scan for diabetic retinopathy susceptibility genes in Mexican Americans with type 2 diabetes from Starr County, Texas. Diabetes 2007; 56(4): 1167-1173.
39. Looker HC, Nelson RG, Chew E, et al. Genome-wide linkage analyses to identify loci for diabetic retinopathy. Diabetes 2007; 56(4): 1160-1166.
40. Uhlmann K, Kovacs P, Boettcher Y, Hammes HP, Paschke R. Genetics of diabetic retinopathy. Exp Clin Endocrinol Diabetes 2006; 114(6): 275-294.
41. Tobi EW, Lumey LH, Talens RP, et al. DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific. Hum Mol Genet 2009; 18(21): 4046-4053.
42. Laborie LB, Mackay DJ, Temple IK, Molven A, Sovik O, Njolstad PR. DNA hypomethylation, transient neonatal diabetes, and prune belly sequence in one of two identical twins. Eur J Pediatr 2010; 169(2): 207-213.
43. Gordon L, Joo JE, Powell JE, et al. Neonatal DNA methylation profile in human twins is specified by a complex interplay between intrauterine environmental and genetic factors, subject to tissue-specific influence. Genome Res 2012; 22(8): 1395-1406.
44. Ollikainen M, Smith KR, Joo EJ, et al. DNA methylation analysis of multiple tissues from newborn twins reveals both genetic and intrauterine components to variation in the human neonatal epigenome. Hum Mol Genet 2010; 19(21): 4176-4188.
45. Lehnen H, Zechner U, Haaf T. Epigenetics of gestational diabetes mellitus and offspring health: the time for action is in early stages of life. Mol Hum Reprod 2013; 19(7): 415-422.
46. Hossein-nezhad A, Holick MF. Optimize dietary intake of vitamin D: an epigenetic perspective. Curr Opin Clin Nutr Metab Care 2012; 15(6): 567-579.
47. Sharma P, Kumar J, Garg G, et al. Detection of altered global DNA methylation in coronary artery disease patients. DNA Cell Biol 2008; 27(7): 357-365.
48. Smolarek I, Wyszko E, Barciszewska AM, et al. Global DNA methylation changes in blood of patients with essential hypertension. Med Sci Monit 2010; 16(3): CR149-CR155.
49. Zhao J, Goldberg J, Bremner JD, Vaccarino V. Global DNA methylation is associated with insulin resistance: a monozygotic twin study. Diabetes 2012; 61(2): 542-546.
50. Katulanda P, Waniganayake YC, Ranasinghe P, et al. Retinopathy among young adults with Diabetes Mellitus from a tertiary care setting in Sri Lanka. BMC Endocr Disord 2014; 14(1): 20.
51. Dudzinska M, Tarach JS, Zwolak A, et al. Type 2 diabetes mellitus in relation to place of residence: evaluation of selected aspects of socio-demographic status, course of diabetes and quality of life - a cross-sectional study. Ann Agric Environ Med 2013; 20(4): 869-874.
52. Maghbooli Z, Pasalar P, Keshtkar A, Farzadfar F, Larijani B. Predictive factors of diabetic complications: a possible link between family history of diabetes and diabetic retinopathy. J Diabetes Metab Disord 2014; 13: 55.